A nurse is preparing to administer total parenteral nutrition to a client. Which of the following actions should the nurse take?
Obtain the client's weight three times a week.
Check the client's WBC count daily.
Keep the solution refrigerated until 1 hr before infusion.
Change the solution every 36 hr.
The Correct Answer is C
allow them to reach room temperature, which reduces the risk of discomfort or complications from infusing a cold solution.
A-Weight measures are not necessary to evaluate the effectiveness of the TPN
B-Daily WBCs are not necessary unless infection is suspected C-Refrigeration of TPN is not necessary
D It is crucial to change the TPN solution regularly to prevent contamination and minimize the risk of infection. Typically, TPN solutions are changed every 24 hours to maintain freshness and reduce the risk of bacterial growth.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is ["A","B","D","E","F"]
Explanation
The medication causes a harmless discoloration or urine (Levodopa causes darkening of urine rather than lightening), high protein intake interferes with the availability of the medication in the CNS, The medication causes orthostatic hypotension and dizziness, The medication should be taken with a meal if nausea and vomiting occurs, Initially the medication can cause dyskinesia which should be reported, The medication also cause hallucinations and sleep disturbances
Correct Answer is D
Explanation
Filgrastim is a medication that stimulates the production of white blood cells (WBCs), particularly neutrophils, which are a type of WBC important for fighting infections. An increase in the WBC count would indicate that filgrastim is effectively stimulating the production of WBCs, which is desirable, especially in clients who are at risk of neutropenia (low WBC count) due to chemotherapy or other factors.
Monitoring potassium levels is important for clients receiving certain medications or experiencing conditions that can affect potassium balance, but it is not specifically related to filgrastim therapy.
BUN is a measure of kidney function and hydration status, but it is not typically monitored to evaluate the effectiveness of filgrastim treatment.
INR is a measure of blood clotting and is primarily monitored in clients receiving anticoagulant therapy, such as warfarin. It is not relevant to filgrastim therapy.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.